MYX 3.56% $4.60 mayne pharma group limited

same asset value after selling Metrics and no debt, page-13

  1. 1,393 Posts.
    lightbulb Created with Sketch. 270
    Been living in hope holding this mangy dog believing still had life in it that was when we still owned MCS we all knew that business and plant worth way more than our entire market cap at the time . Then came along our so called " game changer" plenty of us back then posted Nextstellis will make or break us plain fully obvious we literally couldn't afford it not being successful given what it cost us + holding cost / marketing / establishment cost and financial position , MCS on the line ( syndicated lending loan ). So now what security do we have to offer if our products don't perform as they appear not to be doing . Attempting to get us into a profitable position management seems to have tried buying our way to net profit using money available to us after repaying syndicated lenders , special div., etc . Guessing raising capital if we need to will won't be easy surely can't continue the way we are bleeding capital much longer . Small company run expensively cant see why either. Been a combined effort on the part of old mob and new mob to get us to where we are .
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.